Stay updated on AREDS2 Clinical Trial: Supplement to Prevent Age-Related Macular Degeneration
Sign up to get notified when there's something new on the AREDS2 Clinical Trial: Supplement to Prevent Age-Related Macular Degeneration page.

Latest updates to the AREDS2 Clinical Trial: Supplement to Prevent Age-Related Macular Degeneration page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedAdded a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates potential service delays and open NIH Clinical Center status, plus the updated software version.SummaryDifference2%
- Check15 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; no other content changes detected.SummaryDifference0.1%
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedUpdated page revision to v3.0.2; removed v3.0.1 and the 'Back to Top' link.SummaryDifference0.1%
- Check37 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.1%
- Check44 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and specific locations, while removing redundant location terms. Additionally, a new reference related to antioxidant supplements has been included.SummaryDifference3%
- Check58 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12, indicating a revision in the content.SummaryDifference0.1%
Stay in the know with updates to AREDS2 Clinical Trial: Supplement to Prevent Age-Related Macular Degeneration
Enter your email address, and we'll notify you when there's something new on the AREDS2 Clinical Trial: Supplement to Prevent Age-Related Macular Degeneration page.